Zubradt, Meghan
Gupta, Paromita
Persad, Sitara
Lambowitz, Alan M
Weissman, Jonathan S
Rouskin, Silvi
Article History
Received: 24 June 2016
Accepted: 29 September 2016
First Online: 7 November 2016
Competing interests
: Thermostable group II intron reverse transcriptase (TGIRT) enzymes and methods for their use are the subject of patents and patent applications that have been licensed by the University of Texas and East Tennessee State University to InGex, LLC. A.M.L. and the University of Texas are minority equity holders in InGex, LLC and receive royalty payments from the sale of TGIRT enzymes and the licensing of intellectual property. The other authors declare no competing financial interests.